
Senior Director, HCP Marketing (US)
Scholar Rock, Cambridge, MA, United States
Senior Director, HCP Marketing (US)
The Senior Director, HCP Marketing (US) will play a critical leadership role in the preparation for and execution of Scholar Rock's first U.S. commercial launch. This role will be accountable for developing and driving the U.S. healthcare professional (HCP) marketing strategy and tactical execution for apitegromab, the first and only muscle-targeted therapy for spinal muscular atrophy (SMA). This individual will own the U.S. HCP brand strategy from launch through commercialization, ensuring clear differentiation, compelling scientific communication, and flawless execution across channels. The role will work closely with U.S. commercial, medical, market access, and patient services teams to deliver an integrated launch. In addition to U.S. leadership responsibilities, this role will provide limited ex-U.S. support (~10%), focused on strategic alignment, communication, and knowledge sharing with regional and local teams to ensure consistency of core HCP strategy while respecting local needs. This is a high-impact, high-visibility role within a fast-growing organization and an opportunity to shape the commercial foundation of Scholar Rock's first marketed product. Position Responsibilities: Lead the development of the U.S. HCP brand strategy for apitegromab, grounded in deep understanding of the SMA landscape, unmet need, and clinical data. Own U.S. HCP launch planning, including positioning, messaging, segmentation, targeting, and channel strategy. Translate strategy into high-quality, compliant HCP promotional tactics across personal and non-personal channels. Partner with Sales leadership to ensure strong integration between HCP marketing strategy and field execution. Oversee agency partners and vendors to deliver best-in-class creative and execution. Cross-Functional Leadership: Serve as a core member of the U.S. Marketing Team, collaborating closely with Medical Affairs, Market Access, Patient Services, Regulatory, Legal, and Compliance. Ensure HCP strategy is aligned with scientific narrative, access considerations, and patient support offerings. Provide strategic input into competitive readiness and scenario planning for current and future competitors as well as pipeline considerations. Insights, Performance & Optimization: Leverage market research, customer insights, and performance data to inform strategy and optimize execution. Define key performance indicators and support development of dashboards to track launch performance and drive continuous improvement. Ex-U.S. Alignment (Limited Scope): Partner with ex-U.S. colleagues to share U.S. HCP strategy, learnings, and best practices. Support alignment discussions and ensure effective communication of core brand principles for local adaptation. This role does not own global strategy or local ex-U.S. execution. Candidate Requirements: Bachelor's degree required; advanced degree preferred. 10+ years of experience in pharmaceutical or biotechnology marketing, with significant experience in U.S. HCP marketing. Demonstrated success leading launch-phase HCP marketing for specialty or rare disease products. Experience in neurology, neuromuscular disease, or rare disease strongly preferred. Proven ability to translate complex science into compelling, compliant HCP messaging. Strong strategic mindset with hands-on execution capability. Experience working in matrixed, cross-functional teams in a fast-paced environment. Excellent communication, influence, and stakeholder-management skills. Entrepreneurial mindset with comfort building capabilities in a first-launch environment. Willingness to travel as needed (anticipated up to ~30%). $245,000 - $335,000 a year Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
The Senior Director, HCP Marketing (US) will play a critical leadership role in the preparation for and execution of Scholar Rock's first U.S. commercial launch. This role will be accountable for developing and driving the U.S. healthcare professional (HCP) marketing strategy and tactical execution for apitegromab, the first and only muscle-targeted therapy for spinal muscular atrophy (SMA). This individual will own the U.S. HCP brand strategy from launch through commercialization, ensuring clear differentiation, compelling scientific communication, and flawless execution across channels. The role will work closely with U.S. commercial, medical, market access, and patient services teams to deliver an integrated launch. In addition to U.S. leadership responsibilities, this role will provide limited ex-U.S. support (~10%), focused on strategic alignment, communication, and knowledge sharing with regional and local teams to ensure consistency of core HCP strategy while respecting local needs. This is a high-impact, high-visibility role within a fast-growing organization and an opportunity to shape the commercial foundation of Scholar Rock's first marketed product. Position Responsibilities: Lead the development of the U.S. HCP brand strategy for apitegromab, grounded in deep understanding of the SMA landscape, unmet need, and clinical data. Own U.S. HCP launch planning, including positioning, messaging, segmentation, targeting, and channel strategy. Translate strategy into high-quality, compliant HCP promotional tactics across personal and non-personal channels. Partner with Sales leadership to ensure strong integration between HCP marketing strategy and field execution. Oversee agency partners and vendors to deliver best-in-class creative and execution. Cross-Functional Leadership: Serve as a core member of the U.S. Marketing Team, collaborating closely with Medical Affairs, Market Access, Patient Services, Regulatory, Legal, and Compliance. Ensure HCP strategy is aligned with scientific narrative, access considerations, and patient support offerings. Provide strategic input into competitive readiness and scenario planning for current and future competitors as well as pipeline considerations. Insights, Performance & Optimization: Leverage market research, customer insights, and performance data to inform strategy and optimize execution. Define key performance indicators and support development of dashboards to track launch performance and drive continuous improvement. Ex-U.S. Alignment (Limited Scope): Partner with ex-U.S. colleagues to share U.S. HCP strategy, learnings, and best practices. Support alignment discussions and ensure effective communication of core brand principles for local adaptation. This role does not own global strategy or local ex-U.S. execution. Candidate Requirements: Bachelor's degree required; advanced degree preferred. 10+ years of experience in pharmaceutical or biotechnology marketing, with significant experience in U.S. HCP marketing. Demonstrated success leading launch-phase HCP marketing for specialty or rare disease products. Experience in neurology, neuromuscular disease, or rare disease strongly preferred. Proven ability to translate complex science into compelling, compliant HCP messaging. Strong strategic mindset with hands-on execution capability. Experience working in matrixed, cross-functional teams in a fast-paced environment. Excellent communication, influence, and stakeholder-management skills. Entrepreneurial mindset with comfort building capabilities in a first-launch environment. Willingness to travel as needed (anticipated up to ~30%). $245,000 - $335,000 a year Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.